Your browser doesn't support javascript.
loading
A Comprehensive Review of mRNA Vaccines.
Gote, Vrinda; Bolla, Pradeep Kumar; Kommineni, Nagavendra; Butreddy, Arun; Nukala, Pavan Kumar; Palakurthi, Sushesh Srivatsa; Khan, Wahid.
Afiliação
  • Gote V; Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri, 2464 Charlotte Street, Kansas City, MO 64108, USA.
  • Bolla PK; Department of Biomedical Engineering, College of Engineering, The University of Texas at El Paso, 500 W University Ave, El Paso, TX 79968, USA.
  • Kommineni N; Center for Biomedical Research, Population Council, New York, NY 10065, USA.
  • Butreddy A; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS 38677, USA.
  • Nukala PK; College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Pkwy, Queens, NY 11439, USA.
  • Palakurthi SS; Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, TX 78363, USA.
  • Khan W; Natco Research Centre, NATCO Pharma Limited, Hyderabad 500018, India.
Int J Mol Sci ; 24(3)2023 Jan 31.
Article em En | MEDLINE | ID: mdl-36769023
mRNA vaccines have been demonstrated as a powerful alternative to traditional conventional vaccines because of their high potency, safety and efficacy, capacity for rapid clinical development, and potential for rapid, low-cost manufacturing. These vaccines have progressed from being a mere curiosity to emerging as COVID-19 pandemic vaccine front-runners. The advancements in the field of nanotechnology for developing delivery vehicles for mRNA vaccines are highly significant. In this review we have summarized each and every aspect of the mRNA vaccine. The article describes the mRNA structure, its pharmacological function of immunity induction, lipid nanoparticles (LNPs), and the upstream, downstream, and formulation process of mRNA vaccine manufacturing. Additionally, mRNA vaccines in clinical trials are also described. A deep dive into the future perspectives of mRNA vaccines, such as its freeze-drying, delivery systems, and LNPs targeting antigen-presenting cells and dendritic cells, are also summarized.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas / Nanopartículas / COVID-19 Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas / Nanopartículas / COVID-19 Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article